Gill Capital Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Gill Capital Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$500	Buy	+500	New	+$481	﹤0.01%	634

Other funds holding DRTSW

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Gill Capital Partners's DRTSW Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Alpha Tau Medical Warrant (DRTSW) in Q1 2026: 500 shares worth $500. The stake represents ﹤0.01% of the portfolio and ranks #634 among its holdings.

21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

Gill Capital Partners held 500 shares of Alpha Tau Medical Warrant worth $500 as of Q1 2026.
Alpha Tau Medical Warrant was a new Gill Capital Partners position in Q1 2026.
Alpha Tau Medical Warrant made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #634 holding.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.